Lara Verdian

Lara Verdian MBA MSc is a seasoned professional in healthcare market access and operations, currently serving as the Chief Operating Officer and Head of Healthcare Services at Quant since June 2018. Prior experience includes roles as Director at Deloitte Access Economics and interim Head of International Market Access at Intercept Pharmaceuticals. Lara has held various influential positions in market access at reputable organizations such as GSK, Actelion, Eisai, Pfizer Pharmaceuticals, and Janssen-Cilag. Academically, Lara holds a Master of Business Administration from the University of Technology Sydney, an MSc in International Health Policy from The London School of Economics and Political Science, and a Graduate Certificate in Pharmacoeconomics from Monash University, complemented by a Bachelor’s Degree in Pharmacy from the University of Sydney.